• Store

JOPON Continuing Nursing Education

joponcvr2016APHON offers opportunities to earn continuing nursing education credits online through articles from the Journal of Pediatric Oncology Nursing (JOPON). Online JOPON provides the same CNE approved articles that appear in the printed JOPON online.

APHON members can read the articles and earn 1 CNE per article after taking the post-test and completing the evaluation. You may complete as many articles as you wish, but you cannot use the same article twice for CNE credit. The cost to take the exam and receive CNE credit is $15.00.

CNE Post-Test and Evaluation Details

  1. Click on the “Purchase CNE Test” next to the article below. This link will direct you to purchase the exam in the APHON bookstore.
  2. In the APHON bookstore, click "Add to Cart". In the pop up window, click "Check Out.
  3. If you are not already logged in to the APHON Web site, you will be prompted to log-in. The log-in window will ask for your APHON ID and Password. If you have not yet set up an APHON website account the log-in window will provide instructions to do so.
  4. Once you are logged-in, a new window will open and allow you to purchase the selected post-test. Please note: if you wish to purchase multiple CNE post-tests from the bookstore, you must purchase them all at one time as the Web site will only allow one CNE purchase transaction, per credit card, per day. Once all your purchases have been selected, you may complete your credit card purchase.
  5. Once you have purchased the CNE post-test(s), you will receive an e-mail with instructions on how to access the post-test. Alternatively, you may click on the "View Purchased CNE" link. (If returning to this page at a later time, you will be prompted to enter the ID and password you used at the time of purchase.)

All sales of CNE articles are final and we are unable to issue refunds for duplicate purchases.

JOPON CNE Articles

The individual articles appearing below are approved for continuing nursing education for a period of two years. Please refer to the individual article for specific expiration date.

July/August 2018

Mucormycosis: Early Identification of a Deadly Fungus

Valid July 1, 2018–June 30, 2020

Purchase CNE Test  Download Manuscript

Authors

Ariel M. Brettholz, MS RN PNP and Sabrina Opiola Mccauley, DNP CPNP NNP-BC

Learning Outcomes
  • The learner will be able to describe the pathophysiology, clinical presentations, diagnosis, and management of mucormycosis. 
  • The learner will be able to apply knowledge of mucormycosis in evaluation of patient risk factors, clinical assessments, and provision of patient/family education.
Disclosure

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Individual Learning Needs Assessment (ILNA) Coding

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. Course content applies to multiple content areas across multiple credentials. Individual nurse’s learning plans are linked to the ONCC Test Blueprint for the certification they hold. Review the current test blueprint available on the ONCC website to determine where the content fit.

Psychosocial and Symptom Management

May/June 2018

Measuring the Effects of an Animal-Assisted Intervention for Pediatric Oncology Patients and Their Parents: A Multisite Randomized Controlled Trial

Valid May 1, 2018–April 30, 2020

Purchase CNE Test  Download Manuscript

Authors

Amy McCullough, PhD | Ashleigh Ruehrdanz, MPH | Molly A. Jenkins, MSW | Mary Jo Gilmer, PhD RN-BC FAAN | Janice Olson, MD | Anjali Pawar, MD | Leslie Holley, MS CCLS | Shirley Sierra-Rivera, BSN RN | Deborah E. Linder, DVM MS DACVN | Danielle Pichette, CCRP | Neil J. Grossman, MD | Cynthia Hellman, MSW | Noémi A. Guérin, MS | and Marguerite E. O’Haire, PhD

Learning Outcomes
  • The learner will be able to describe effects of animal-assisted intervention (AAI) on stress, anxiety, and health-related quality of life for children with cancer and their parents.
  • The learner will be able to apply knowledge to support AAI as an adjunctive treatment modality and psychosocial intervention for children with cancer and their families. 
Disclosure

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Individual Learning Needs Assessment (ILNA) Coding

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. Course content applies to multiple content areas across multiple credentials. Individual nurse’s learning plans are linked to the ONCC Test Blueprint for the certification they hold. Review the current test blueprint available on the ONCC website to determine where the content fit.

Coordination of Care, Oncologic Emergencies, Professional Practice, Scientific Basis for Practice, Survivorship, Symptom Management, Treatment

March/April 2018

Clinical Characteristics of Intravenous PEG-Asparaginase Hypersensitivity Reactions in Patients Undergoing Treatment for Acute Lymphoblastic Leukemia

Valid March 1, 2018–February 28, 2020

Purchase CNE Test  Download Manuscript

Authors

Emily K. Browne, DNP RN CPNP | Christina Moore, BS | April Sykes, MPH | Zhaohua Lu, PhD | Sima Jeha, MD |  Belinda N. Mandrell, PhD RN CPNP

Learning Outcomes
  • The learner will be able to identify patient and treatment phase factors leading to greatest risk for developing an intravenous (IV) PEG-asparaginase hypersensitivity reaction.
  • The learner will be able to distinguish between clinical characteristics of the four grades of infusion-related hypersensitivity reactions with PEG-asparaginase.
  • The learner will be able to describe necessary nursing observations and patient monitoring during intravenous (IV) PEG-asparaginase treatment.
Disclosure

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Individual Learning Needs Assessment (ILNA) Coding

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

CPHON® Blueprint

Oncologic Emergencies, Symptom Management OR Treatment

January/February 2018

Facilitators and Barriers to Self-Management for Adolescents and Young Adults Following A Hematopoietic Stem Cell Transplant

Valid January 1, 2018–December 31, 2019

Purchase CNE Test Download Manuscript

Authors

Caroline F. Morrison, PhD RN | Ahna L. H. Pai, PhD | and Donna Martsolf, PhD RN FAAN

Learning Outcomes
  • The learner will be able to apply knowledge of facilitators and barriers to better promote self-management for adolescents and young adults (AYA) undergoing hematopoietic stem cell transplant.
  • The learner will be able to utilize effective communication, holistic care, and social support to assist AYA in self-management.
Disclosure

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Individual Learning Needs Assessment (ILNA) Coding

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

CPHON® Blueprint

Psychosocial or Professional

BMTCN® Blueprint

Post-Transplant Issues

November/December 2017

Review of the Effectiveness of Enteral Feeding in Pediatric Oncology Patients

Valid November 1, 2017–December 31, 2019

Authors

Kaleena Trimpe, MN RN NP-C | Michele R. Shaw, PhD RN | Marian Wilson, PhD MPH RN-BC | Mel R. Haberman, PhD RN FAAN

Learning Outcomes
  • The learner will be able to discuss the safety and effectiveness of enteral feeding in pediatric oncology patients.
  • The learner will be able to apply knowledge regarding enteral feeding to clinical practice.
Disclosure

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Individual Learning Needs Assessment (ILNA) Coding

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

CPHON® Blueprint

Symptom Management

September/October 2017

The Relationship of Genetics, Nursing Practice, and Informatics Tools in 6-Mercaptopurine Dosing in Pediatric Oncology

Valid September 1, 2017–October 31, 2019

Purchase CNE Test Download Manuscript

Author

Wendy J. Haylett, MSN, RN, CPON

Learning Outcomes
  • The learner will be able to identify informatics tools useful in supporting the care of patients prescribed 6-MP.
  • The learner will be able to apply knowledge of pharmacogenetics related to 6-MP dosing to clinical practice.
Disclosure

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Individual Learning Needs Assessment (ILNA) Coding

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

CPHON® Blueprint

Treatment Modalities OR Professional

July/August 2017

Development of a mHealth Real-Time Pain Self-Management App for Adolescents With Cancer: An Iterative Usability Testing Study

Valid July 1, 2017–August 31, 2019

Purchase CNE Test Download Manuscript

Authors

Lindsay A. Jibb, PhD RN | Joseph A. Cafazzo, PhD PEng | Paul C. Nathan, MD MSc | Emily Seto, PhD PEng | Bonnie J. Stevens, PhD RN | Cynthia Nguyen, MPH | Jennifer N. Stinson, PhD RN-EC

Learning Outcomes
  • The learner will be able to describe the potential usefulness of a real-time pain self-management app for adolescents with cancer and distinguish ways by which healthcare providers may best support the use of smartphone applications.
  • The learner will be able to describe the testing necessary in the development of a mobile-based app for patient self-management.
  • The learner will be able to recognize the impact of cancer pain on the adolescent population.
Disclosure

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Individual Learning Needs Assessment (ILNA) Coding

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

CPHON® Blueprint

Supportive Care and Symptom Management, Palliative and End of Life Care OR Professional Performance.

May/June 2017

Using Practice-Based Evidence to Improve Supportive Care Practices to Reduce Central Line–Associated Bloodstream Infections in a Pediatric Oncology Unit

Valid May 1, 2017–May 31, 2019

Purchase CNE Test Download Manuscript

Authors

Lauri A. Linder, PhD APRN CPON® | Cheryl Gerdy, MSN RN CPON® | Rouett Abouzelof, MS RN; Andrew Wilson, PhD MStat

Learning Outcomes
  • The learner will be able to describe the principles of practice-based evidence and use these principles in guiding the development of interventions to improve clinical care.
  • The learner will be able to apply the findings of the project described in this article to reduce the incidence of central line-associated bloodstream infections in clinical practice settings.
Disclosure

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Individual Learning Needs Assessment (ILNA) Coding

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

CPHON® Blueprint

Supportive Care and Symptom Management

March/April 2017

Nursing Implications for the Management of Lymphatic Malformation in Children

Valid March 1, 2017–February 28, 2019

Purchase CNE Test Download Manuscript

Author

Rebecca Berger, MSN RN ARNP

Learning Outcomes
  • The learner will be able to identify types of vascular anomalies and medical treatments available to children with lymphatic malformations.
  • The learner will be able to identify types of vascular anomalies and medical treatments available to children with lymphatic malformations.
Disclosure

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author received no financial support for the research, authorship, and/or publication of this article.

Individual Learning Needs Assessment (ILNA) Coding

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

CPHON® Blueprint

Treatment

January/February 2017

Dinutuximab: A Novel Immunotherapy in the Treatment of Pediatric Patients With High-Risk Neuroblastoma

Valid January 1, 2017–December 31, 2019

Purchase CNE Test Download Manuscript

Authors

Joy Bartholomew, APRN | Tanea Washington, APRN | Sharon Bergeron, BSN | Danelle Nielson, APRN | Jennifer Saggio, APRN | Lindsay Quirk, APRN

Learning Outcomes
  • The learner will have expanded knowledge of immunotherapy treatment for high-risk neuroblastoma.
  • The learner will acquire knowledge relevant for management of immunotherapy side effects.
Disclosure

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author received no financial support for the research, authorship, and/or publication of this article.

Individual Learning Needs Assessment (ILNA) Coding

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

CPHON® Blueprint

Treatment

November/December 2016

Understanding Effective Delivery of Patient and Family Education in Pediatric Oncology: A Systematic Review From the Children’s Oncology Group

Valid November 1, 2016–October 31, 2018

Purchase CNE Test Download Manuscript

Authors

Cheryl C. Rodgers, PhD RN CPNP CPON® | Catherine M. Laing, PhD RN | Ruth Anne Herring, MSN RN CPNP CPHON® | Nancy Tena, MSN RN CNS-BC CPHON® BMTCN® | Adrianne Leonardelli, MLIS | Marilyn Hockenberry, PhD RN PPCNP FAAN | Verna Hendricks-Ferguson, PhD RN CHPPN FPCN FAAN

Learning Objectives
  • Identify evidence related to teaching methods, educational content, and factors influencing education of children newly diagnosed with cancer and their family members.
  • Recognize effective educational strategies for children newly diagnosed with cancer and their family members.
Disclosure

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author received no financial support for the research, authorship, and/or publication of this article.

Individual Learning Needs Assessment (ILNA) Coding

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

CPHON® Blueprint

Professional Performance

BMTCN® Blueprint

Professional Performance

September/October 2016

Hydroxyurea in Pediatric Patients With Sickle Cell Disease: What Nurses Need to Know

Valid September 1, 2016–August 31, 2018

Purchase CNE Test Download Manuscript

Author

Allison L. Rees, MSN, RN

Learning Objectives
  • Review the 2014 National Heart Lung and Blood Institute Guidelines for the use of hydroxyurea in pediatric patients.
  • Describe hydroxyurea treatment for pediatric patients with sickle disease.
Disclosure

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author received no financial support for the research, authorship, and/or publication of this article.

Individual Learning Needs Assessment (ILNA) Coding

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

CPHON® Blueprint

Treatment

Accreditation and Disclaimers

ONCC Official Statement and Disclaimer

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. ONCC review is only for designating content to be used for recertification points and is not for CNE accreditation. CNE programs must be formally approved for contact hours by an acceptable accreditor/approver of nursing CE to be used for recertification by ONCC. If the CNE provider fails to obtain formal approval to award contact hours by an acceptable accrediting/approval body, no information related to ONCC recertification may be used in relation to the program. 

Have questions regarding the CPHON® or BMTCN® ILNA Coding? Please visit the ONCC website or call them toll-free at 877.769.ONCC (US and Canada only).

Accreditation Statement

The Association of Pediatric Hematology/Oncology Nurses (APHON) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Disclosures

If there are any disclosures to report, they will be indicated in the individual activity.